• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Sleep Cycle signs commercial SDK licensing agreement with Ultrahuman following successful pilot

SLEEPPress release2026-07-03 07:30

Sleep Cycle, the leading AI-powered sleep technology company, today announced that it has signed a commercial licensing agreement with Ultrahuman, a global health and wearable technology company. The agreement governs Ultrahuman’s continued use of Sleep Cycle’s proprietary Sleep SDK and follows a successful pilot collaboration initiated in November 2025.

The pilot was established to evaluate how Sleep Cycle’s audio-based sleep and respiratory intelligence could strengthen Ultrahuman’s health platform. The Respiratory Health PowerPlug combined Sleep Cycle’s sleep and respiratory intelligence with biometric signals from Ultrahuman Ring to reveal patterns, trends, and changes in snoring, coughing and respiratory disturbances.

During the pilot period, Ultrahuman's Respiratory Health PowerPlug became one of Ultrahuman's best-performing PowerPlugs. Following these results, the parties have agreed to expand the collaboration under a commercial SDK licensing agreement.

Under the agreement, Ultrahuman will continue to integrate Sleep Cycle’s technology into its platform under the “Powered by Sleep Cycle” framework. Sleep Cycle’s revenue is linked to adoption and growth within the Ultrahuman ecosystem, aligning the interests of both parties as the collaboration scales.

“The pilot demonstrated that our technology creates value not only in our own application, but also within partner ecosystems. Moving from pilot to commercial agreement with Ultrahuman is an important milestone for our Powered by Sleep Cycle strategy and further validates the demand for our technology in the global health and wearables market,” says Erik Jivmark, CEO of Sleep Cycle.

“Breathing disruptions that fragment sleep are linked to long-term cardiovascular risk, yet they remain largely invisible to most people. The success of the Respiratory Health PowerPlug, which is powered by Sleep Cycle, demonstrated the value of making these signals accessible and actionable, which supports long-term health outcomes, while complementing the broader health ecosystem we're building. We're excited to deepen this partnership and accelerate the future of preventive health," says Mohit Kumar, Founder and CEO of Ultrahuman.

The agreement represents an important milestone in Sleep Cycle’s Powered by Sleep Cycle licensing strategy and further demonstrates the applicability of the company’s technology beyond its own consumer application.

For more information, please contact:

Erik Jivmark | CEO
erik.jivmark@sleepcycle.com

Elisabeth Hedman | CFO & Head of IR
elisabeth.hedman@sleepcycle.com | +46 76 282 8958

About Sleep Cycle
Sleep Cycle is dedicated to making healthy sleep accessible to everyone. Our app helps users to build hero habits, identify potential sleep issues, and gain valuable insights into their sleep patterns. Leveraging patented sound technology and over 3 billion analyzed sleep sessions, Sleep Cycle provides unparalleled accuracy and personalized guidance. As part of its broader partnership program, Sleep Cycle offers company partnerships including in-app promotions, tailored SDK solutions, and an extensive data library, enabling businesses to expand their offerings with sleep solutions and insights. Sleep Cycle is listed on Nasdaq Stockholm under the ticker SLEEP, with its headquarters in Gothenburg, Sweden.

Attachments
Sleep Cycle signs commercial SDK licensing agreement with Ultrahuman following successful pilot